These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22514693)

  • 1. Collaborative enhancement of antibody binding to distinct PECAM-1 epitopes modulates endothelial targeting.
    Chacko AM; Nayak M; Greineder CF; Delisser HM; Muzykantov VR
    PLoS One; 2012; 7(4):e34958. PubMed ID: 22514693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1.
    Kiseleva R; Greineder CF; Villa CH; Hood ED; Shuvaev VV; Sun J; Chacko AM; Abraham V; DeLisser HM; Muzykantov VR
    PLoS One; 2017; 12(1):e0169537. PubMed ID: 28085903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.
    Chacko AM; Han J; Greineder CF; Zern BJ; Mikitsh JL; Nayak M; Menon D; Johnston IH; Poncz M; Eckmann DM; Davies PF; Muzykantov VR
    ACS Nano; 2015 Jul; 9(7):6785-93. PubMed ID: 26153796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes.
    Garnacho C; Albelda SM; Muzykantov VR; Muro S
    J Control Release; 2008 Sep; 130(3):226-33. PubMed ID: 18606202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalent engagement of endothelial surface antigens is critical to prolonged surface targeting and protein delivery in vivo.
    Kiseleva RY; Glassman PG; LeForte KM; Walsh LR; Villa CH; Shuvaev VV; Myerson JW; Aprelev PA; Marcos-Contreras OA; Muzykantov VR; Greineder CF
    FASEB J; 2020 Sep; 34(9):11577-11593. PubMed ID: 32738178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial effects of collaborative binding to platelet/endothelial cell adhesion molecule-1 (PECAM-1).
    Kiseleva RY; Greineder CF; Villa CH; Marcos-Contreras OA; Hood ED; Shuvaev VV; DeLisser HM; Muzykantov VR
    Sci Rep; 2018 Jan; 8(1):1510. PubMed ID: 29367646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect.
    Greineder CF; Brenza JB; Carnemolla R; Zaitsev S; Hood ED; Pan DC; Ding BS; Esmon CT; Chacko AM; Muzykantov VR
    FASEB J; 2015 Aug; 29(8):3483-92. PubMed ID: 25953848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment.
    Nakada MT; Amin K; Christofidou-Solomidou M; O'Brien CD; Sun J; Gurubhagavatula I; Heavner GA; Taylor AH; Paddock C; Sun QH; Zehnder JL; Newman PJ; Albelda SM; DeLisser HM
    J Immunol; 2000 Jan; 164(1):452-62. PubMed ID: 10605042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor.
    Greineder CF; Chacko AM; Zaytsev S; Zern BJ; Carnemolla R; Hood ED; Han J; Ding BS; Esmon CT; Muzykantov VR
    PLoS One; 2013; 8(11):e80110. PubMed ID: 24244621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature.
    Scherpereel A; Rome JJ; Wiewrodt R; Watkins SC; Harshaw DW; Alder S; Christofidou-Solomidou M; Haut E; Murciano JC; Nakada M; Albelda SM; Muzykantov VR
    J Pharmacol Exp Ther; 2002 Mar; 300(3):777-86. PubMed ID: 11861781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting.
    Danilov SM; Gavrilyuk VD; Franke FE; Pauls K; Harshaw DW; McDonald TD; Miletich DJ; Muzykantov VR
    Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1335-47. PubMed ID: 11350815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.
    Muzykantov VR; Christofidou-Solomidou M; Balyasnikova I; Harshaw DW; Schultz L; Fisher AB; Albelda SM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2379-84. PubMed ID: 10051650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1.
    Han J; Shuvaev VV; Davies PF; Eckmann DM; Muro S; Muzykantov VR
    J Control Release; 2015 Jul; 210():39-47. PubMed ID: 25966362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotargeting of glucose oxidase: intracellular production of H(2)O(2) and endothelial oxidative stress.
    Gow AJ; Branco F; Christofidou-Solomidou M; Black-Schultz L; Albelda SM; Muzykantov VR
    Am J Physiol; 1999 Aug; 277(2):L271-81. PubMed ID: 10444521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1.
    Garnacho C; Shuvaev V; Thomas A; McKenna L; Sun J; Koval M; Albelda S; Muzykantov V; Muro S
    Blood; 2008 Mar; 111(6):3024-33. PubMed ID: 18182571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes.
    Papademetriou I; Tsinas Z; Hsu J; Muro S
    J Control Release; 2014 Aug; 188():87-98. PubMed ID: 24933603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICAM-1-activated Src and eNOS signaling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration.
    Liu G; Place AT; Chen Z; Brovkovych VM; Vogel SM; Muller WA; Skidgel RA; Malik AB; Minshall RD
    Blood; 2012 Aug; 120(9):1942-52. PubMed ID: 22806890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates.
    Shuvaev VV; Tliba S; Pick J; Arguiri E; Christofidou-Solomidou M; Albelda SM; Muzykantov VR
    J Control Release; 2011 Feb; 149(3):236-41. PubMed ID: 21044652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery.
    Dan M; Cochran DB; Yokel RA; Dziubla TD
    PLoS One; 2013; 8(11):e81051. PubMed ID: 24278373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding properties and inhibition of platelet aggregation by a monoclonal antibody to CD31 (PECAM-1).
    Wu XW; Lian EC
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3154-8. PubMed ID: 9409305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.